ESC 365 - Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

HFA Premium Access

Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

Session: Poster Session 1 - Pharmacology and Pharmacotherapy

Topic: Angiotensin-Renin-Bradykinin System

Speaker: Doctor C. Goena Vives (Donostia, ES)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)

3 presentations

0 follower

10 more presentations in this session

Sacubitril valsartan in real life: tolerance, clinical evolution and remodeled long term

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus

Speaker: Doctor R. Bravo-Marques (Marbella, ES)

Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction

Speaker: Doctor F. Fonseca Goncalves (Vila Real, PT)

Diabetic patients need higher loop diuretic doses: a report on acute and chronic heart failure patients

Speaker: Associate Professor P. Bettencourt (Porto, PT)

Progression of markers of cardiac structure and function in the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) clinical trial

Speaker: Professor M. Ledwidge (Dublin, IE)

Access the full session

Poster Session 1 - Pharmacology and Pharmacotherapy

Speakers: Doctor C. Goena Vives, Doctor R. Bravo-Marques, Doctor R. Bravo-Marques, Doctor F. Fonseca Goncalves, Associate Professor P. Bettencourt...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources